09:54 AM EST - Amorfix Life Sciences : announced that the Company is collaborating with Helix BioPharma to develop novel therapeutics against cancers associated with misfolded prion protein. These novel therapeutics will specifically target tumour cells and are expected to be more effective and safer than traditional cancer treatments. Amorfix Life Sciences
shares T.AMF are trading up $0.015 at $0.23.
